deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 3-arm NCT03984097

A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

An Open-Label, Multicenter Phase 1b Study Investigating the Safety of TAK-079 in Combination With Backbone Regimens for the Treatment of Patients With Newly Diagnosed Multiple Myeloma and for Whom Stem Cell Transplantation Is Not Planned as Initial Therapy

Sponsor: Takeda

Conditions Multiple Myeloma
Interventions Bortezomib Dexamethasone Lenalidomide Pomalidomide TAK-079
Updated 21 times since 2019 Last updated: Mar 9, 2026 Started: Jul 29, 2019 Primary completion: Mar 25, 2026 Completion: Mar 25, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Multiple Myeloma, this trial is ongoing. The trial is conducted by Takeda and has accumulated 21 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2019 – ~Oct 2019 · 3 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Oct 2020 · 3 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshot~Aug 2023 – ~May 2024 · 9 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Feb 2026 · 11 months · monthly snapshot~Feb 2026 – ~Mar 2026 · 28 days · monthly snapshot~Mar 2026 – present · 4 months · monthly snapshot

Change History

21 versions recorded

  1. Mar 2026 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Feb 2026 — Mar 2026 [monthly]

    Active Not Recruiting PHASE1

  3. Mar 2025 — Feb 2026 [monthly]

    Active Not Recruiting PHASE1

  4. Sep 2024 — Mar 2025 [monthly]

    Active Not Recruiting PHASE1

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

▶ Show 16 earlier versions

  1. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

  2. Aug 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE1

  3. Sep 2022 — Aug 2023 [monthly]

    Active Not Recruiting PHASE1

  4. Sep 2021 — Sep 2022 [monthly]

    Active Not Recruiting PHASE1

  5. Apr 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  6. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE1

  7. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1

  8. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  9. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

  10. Jul 2020 — Oct 2020 [monthly]

    Recruiting PHASE1

    Status: Active Not Recruiting → Recruiting

  11. Jun 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  12. Feb 2020 — Jun 2020 [monthly]

    Recruiting PHASE1

  13. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE1

  14. Nov 2019 — Jan 2020 [monthly]

    Recruiting PHASE1

  15. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  16. Jul 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Takeda
Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations